Connor, Clark & Lunn Investment Management Ltd. Kezar Life Sciences, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
SELL
$3.13 - $7.31 $352,794 - $823,939
-112,714 Reduced 55.91%
88,899 $278,000
Q4 2022

Feb 10, 2023
SELL
$6.39 - $8.8 $454,098 - $625,363
-71,064 Reduced 26.06%
201,613 $1.42 Million
Q3 2022

Nov 10, 2022
BUY
$7.99 - $10.75 $242,272 - $325,961
30,322 Added 12.51%
272,677 $2.35 Million
Q2 2022

Aug 05, 2022
BUY
$4.58 - $17.13 $1.11 Million - $4.15 Million
242,355 New
242,355 $2 Million

Others Institutions Holding KZR

# of Institutions
61
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email